Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 220 participants.
Also called NCT07865221
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 220 participants
- Registry
-
NCT07865221
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07865221. Randomized; single masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2028-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection
- Condition
- Paroxysmal Atrial Fibrillation
- Condition
- Pulsed Field Ablation
- Condition
- Catheter Ablation
- Condition
- Left Atrial Function
- Condition
- Cardiology
- Intervention (Device)
- Novel Pulsed Field Ablation System
- Intervention (Device)
- Radiofrequency Ablation Catheter
- Lead sponsor
- Tianjin Medical University General Hospital
Record details
- Record id
cardio:ct-nct07865221- Content hash
4dee0b1aec23d3d998b9f5b71111de688ecaec19221c69227806a8473250bcc7